Compugen Stock Price Prediction

CGEN Stock  USD 1.41  0.04  2.76%   
As of today, The relative strength index (RSI) of Compugen's share price is at 50 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Compugen, making its price go up or down.

Oversold Vs Overbought

50

 
Oversold
 
Overbought
The successful prediction of Compugen's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Compugen, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Compugen's stock price prediction:
EPS Estimate Next Quarter
0.06
EPS Estimate Current Year
(0.16)
EPS Estimate Next Year
(0.27)
Wall Street Target Price
4
EPS Estimate Current Quarter
0.1
Using Compugen hype-based prediction, you can estimate the value of Compugen from the perspective of Compugen response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Compugen to buy its stock at a price that has no basis in reality. In that case, they are not buying Compugen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Compugen after-hype prediction price

    
  USD 1.39  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Compugen Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Compugen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.112.195.68
Details
Naive
Forecast
LowNextHigh
0.031.294.78
Details
3 Analysts
Consensus
LowTargetHigh
4.254.675.18
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.04-0.04-0.04
Details

Compugen After-Hype Price Prediction Density Analysis

As far as predicting the price of Compugen at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Compugen or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Compugen, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Compugen Estimiated After-Hype Price Volatility

In the context of predicting Compugen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Compugen's historical news coverage. Compugen's after-hype downside and upside margins for the prediction period are 0.07 and 4.88, respectively. We have considered Compugen's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.41
1.39
After-hype Price
4.88
Upside
Compugen is very risky at this time. Analysis and calculation of next after-hype price of Compugen is based on 3 months time horizon.

Compugen Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Compugen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Compugen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Compugen, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.51 
3.49
  0.02 
  0.03 
8 Events / Month
12 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.41
1.39
1.42 
11,633  
Notes

Compugen Hype Timeline

Compugen is currently traded for 1.41. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.03. Compugen is forecasted to decline in value after the next headline, with the price expected to drop to 1.39. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.42%, whereas the daily expected return is currently at -0.51%. The volatility of related hype on Compugen is about 5235.0%, with the expected price after the next announcement by competition of 1.44. About 15.0% of the company shares are held by institutions such as insurance companies. The book value of Compugen was currently reported as 0.74. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Compugen Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.

Compugen Related Hype Analysis

Having access to credible news sources related to Compugen's direct competition is more important than ever and may enhance your ability to predict Compugen's future price movements. Getting to know how Compugen's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Compugen may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
PHGEBiomx Inc(0.03)4 per month 0.00 (0.28) 5.56 (8.33) 29.33 
PLURPluri Inc 0.47 3 per month 4.68 (0.01) 8.53 (8.45) 21.61 
SURFSurface Oncology(0.18)3 per month 3.13  0.12  8.51 (5.05) 24.63 
BLRXBioLineRx(0.02)3 per month 0.00 (0.19) 4.88 (9.80) 59.21 
ITOSIteos Therapeutics(0.44)7 per month 0.00 (0.26) 4.26 (4.52) 33.24 
ICVXIcosavax(0.11)1 per month 4.56  0.13  10.22 (6.79) 38.57 
MRTXMirati Ther 0.00 0 per month 0.00 (0.18) 4.02 (4.07) 16.13 
VECTVectivBio Holding AG 0.06 7 per month 0.88  0.19  5.61 (3.08) 39.30 
ANNXAnnexon 0.04 9 per month 0.00 (0.07) 6.98 (5.26) 23.00 
ALLOAllogene Therapeutics(0.07)8 per month 0.00 (0.05) 9.84 (8.09) 23.67 
BEAMBeam Therapeutics 1.18 9 per month 3.59 (0) 7.79 (7.94) 20.75 
SANASana Biotechnology(0.20)9 per month 0.00 (0.27) 7.20 (8.07) 23.40 
CRBUCaribou Biosciences(0.13)7 per month 4.67 (0.01) 7.42 (6.63) 28.53 
EDITEditas Medicine 0.26 9 per month 0.00 (0.17) 7.41 (6.42) 24.40 
CANFCan Fite Biopharma 0.03 4 per month 0.00 (0.06) 7.24 (6.03) 21.59 
ICCCImmuCell(0.12)6 per month 2.33 (0.02) 3.40 (3.29) 21.64 
EVGNEvogene 0.05 3 per month 0.00 (0.22) 9.30 (6.91) 36.00 
CLGNCollplant Biotechnologies 0.41 2 per month 0.00 (0.13) 4.69 (5.10) 14.36 

Compugen Additional Predictive Modules

Most predictive techniques to examine Compugen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Compugen using various technical indicators. When you analyze Compugen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Compugen Predictive Indicators

The successful prediction of Compugen stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Compugen, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Compugen based on analysis of Compugen hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Compugen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Compugen's related companies.
 2021 2022 2023 2024 (projected)
PB Ratio3.390.82.673.68
Capex To Depreciation0.631.010.360.66

Story Coverage note for Compugen

The number of cover stories for Compugen depends on current market conditions and Compugen's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Compugen is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Compugen's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Compugen Short Properties

Compugen's future price predictability will typically decrease when Compugen's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Compugen often depends not only on the future outlook of the potential Compugen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Compugen's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding87.6 M
Cash And Short Term Investments51 M
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Compugen Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.03
Revenue Per Share
0.48
Quarterly Revenue Growth
3.461
Return On Assets
(0.03)
Return On Equity
(0.16)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.